Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VENETOCLAX vs VERTEPORFIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VENETOCLAX vs VERTEPORFIN: Safety Overview

Metric VENETOCLAX VERTEPORFIN
Total FAERS Reports 53,724 753
Deaths Reported 15,763 19
Death Rate 29.3% 2.5%
Hospitalizations 20,812 46
Average Patient Age 67.9 yrs 68.4 yrs
% Female Patients 37.6% 31.1%
FDA Approval Date Apr 11, 2016 Apr 12, 2000
Manufacturer AbbVie Inc. Bausch Health US LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription